PARI WORLDWIDE

PARI Pharma is focused on new aerosol aerosol
An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas.
delivery technology and pharmaceutical formulation development together under one roof. PARI Pharma's core competencies include Advanced Aerosol Aerosol
An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas.
Delivery Platform development, engineering, aerosol aerosol
An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas.
testing, product manufacturing, and medication formulation optimization for eFlow Technology devices.

Because eFlow Technology devices provide the potential for significantly reduced medication doses and treatment times, PARI Pharma is in the unique position of helping pharmaceutical companies develop innovative new medication formulations with customized drug-device matching. The potential for creating improved formulations, or new uses for approved active ingredients, is also greater with eFlow due to its innovative technology platform.

Primary Products: Advanced Aerosol Aerosol
An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas.
Platforms including eFlow (Pulmonary) and Vibrent (Sinus) Technologies and formulations optimized for these platforms.

Country selection